Skip to content

Extended trough level measurement with extended release formulation of tacrolimus

Extended trough level measurement with extended release formulation of tacrolimus - Advadal

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34374
Enrollment
24
Registered
2011-01-06
Start date
2011-12-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal transplantation

Interventions

None listed

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Recipient of a renal graft 2. Age: 18 years or older 3. Informed consent 4. At least 2 months after renal transplantation 5. Treatment with tacrolimus OD 6. Tacrolimus trough levels within the target range (5-10 ug/l) at two subsequent occasions.

Exclusion criteria

Exclusion criteria: 1. Severe diarrhea (> 3 stools per day) 2. Change in tacrolimus dosage within one week prior to inclusion

Design outcomes

Primary

MeasureTime frame
The difference between trough levels measured at 24 hours and at 32 hours after taking of tacrolimus OD.

Secondary

MeasureTime frame
The extent of correlation between these two measurements

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)